Key Financial Inc Has $3.08 Million Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Key Financial Inc lessened its position in The Procter & Gamble Company (NYSE:PGFree Report) by 0.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,031 shares of the company’s stock after selling 68 shares during the period. Procter & Gamble comprises about 0.8% of Key Financial Inc’s portfolio, making the stock its 25th largest holding. Key Financial Inc’s holdings in Procter & Gamble were worth $3,082,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Emerald Advisors LLC grew its holdings in Procter & Gamble by 1.8% during the 4th quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock worth $553,000 after acquiring an additional 65 shares in the last quarter. O Brien Wealth Partners LLC boosted its holdings in Procter & Gamble by 3.3% in the 4th quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock valued at $302,000 after purchasing an additional 65 shares in the last quarter. KFA Private Wealth Group LLC boosted its position in shares of Procter & Gamble by 2.2% during the 3rd quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock worth $445,000 after purchasing an additional 67 shares in the last quarter. Chemistry Wealth Management LLC grew its position in Procter & Gamble by 1.2% during the fourth quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock worth $856,000 after buying an additional 67 shares during the period. Finally, Watchman Group Inc. grew its holdings in shares of Procter & Gamble by 0.4% in the 3rd quarter. Watchman Group Inc. now owns 18,052 shares of the company’s stock worth $2,633,000 after acquiring an additional 68 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of PG traded up $1.01 on Wednesday, reaching $156.96. 6,500,779 shares of the stock traded hands, compared to its average volume of 6,850,489. The firm has a market cap of $369.33 billion, a price-to-earnings ratio of 26.12, a P/E/G ratio of 3.18 and a beta of 0.44. The Procter & Gamble Company has a 12 month low of $141.45 and a 12 month high of $163.14. The stock’s 50-day moving average price is $159.20 and its 200-day moving average price is $152.77. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.64 and a quick ratio of 0.44.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Tuesday, January 23rd. The company reported $1.84 earnings per share for the quarter, beating analysts’ consensus estimates of $1.70 by $0.14. The business had revenue of $21.44 billion for the quarter, compared to analysts’ expectations of $21.48 billion. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The firm’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.59 earnings per share. Equities analysts forecast that The Procter & Gamble Company will post 6.45 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a $1.0065 dividend. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. This represents a $4.03 annualized dividend and a yield of 2.56%. Procter & Gamble’s payout ratio is currently 62.98%.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Gary A. Coombe sold 22,000 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the sale, the chief executive officer now directly owns 36,845 shares in the company, valued at approximately $5,943,835.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, insider Marc S. Pritchard sold 101,704 shares of the business’s stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $153.57, for a total value of $15,618,683.28. Following the completion of the sale, the insider now directly owns 163,428 shares in the company, valued at approximately $25,097,637.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Gary A. Coombe sold 22,000 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the sale, the chief executive officer now owns 36,845 shares of the company’s stock, valued at $5,943,835.40. The disclosure for this sale can be found here. Insiders have sold 279,063 shares of company stock worth $43,187,745 over the last three months. Company insiders own 0.17% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on PG shares. Stifel Nicolaus increased their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research report on Wednesday, January 24th. JPMorgan Chase & Co. reduced their target price on shares of Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a report on Thursday, January 18th. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. The Goldman Sachs Group initiated coverage on Procter & Gamble in a research note on Friday, March 1st. They issued a “neutral” rating and a $168.00 price target on the stock. Finally, Barclays upped their price target on shares of Procter & Gamble from $165.00 to $168.00 and gave the stock an “overweight” rating in a research report on Friday, April 12th. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $168.53.

Read Our Latest Report on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.